MetaCap

Bioventus (BVS) vs Tactile Systems Technology (TCMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bioventus (BVS) has outperformed Tactile Systems Technology (TCMD) over the past year, gaining 36.5% versus a loss of 0.4%. Over five years, TCMD leads with a +23.9% price change compared with -21.0% for BVS. Bioventus is the larger company by market cap ($676.5 million vs $573.5 million), about 1.2 times the size, while Tactile Systems Technology is growing revenue faster (+12.5% vs -0.9%).

On valuation, Bioventus trades at a lower forward P/E (11.1x vs 17.4x for Tactile Systems Technology). Tactile Systems Technology converts more of its revenue into profit, with a net margin of 5.8% versus 4.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BVS+36.46%TCMD-0.39%
+117%+48%-22%
Nov 21, 20251 yearNov 20, 2026
BVS-29.53%TCMD+8.66%
+39%-30%-99%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BVS versus TCMD key metrics
MetricBVSTCMD
Share price$9.88$25.60
Market cap$676.53M$573.48M
1-day change-0.70%-1.50%
YTD return+32.80%-11.72%
1-year return+36.46%-0.39%
5-year return-21.02%+23.85%
P/E ratio (TTM)12.2024.85
Forward P/E11.1317.41
EPS (TTM)$0.81$1.03
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$568.09M$329.52M
Revenue growth (YoY)-0.91%+12.47%
Net income (latest FY)$22.73M$19.09M
Gross margin68.33%75.91%
Operating margin9.50%8.89%
Net margin4.00%5.79%
52-week high$15.89$37.77
52-week low$7.02$20.53
Distance from 52-week high-37.83%-32.22%
Analyst consensusnonestrong_buy
Avg. price target upside+68.02%+41.91%
Average volume536.81K248.63K
Shares outstanding68.47M22.40M
Employees9601,086
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • BVS has outperformed TCMD by 36.9 percentage points over the past year.
  • Tactile Systems Technology trades at a higher earnings multiple (24.9x vs 12.2x trailing P/E).
  • Tactile Systems Technology grew revenue faster in its latest fiscal year (+12.47% vs -0.91%).

About Bioventus

BVS stock →

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle.

Health Care · Medical/Dental Instruments · 960 employees

About Tactile Systems Technology

TCMD stock →

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.

Health Care · Medical/Dental Instruments · 1,086 employees

BVS vs TCMD FAQ

Which is bigger, Bioventus or Tactile Systems Technology?

Bioventus (BVS) is larger, with a market capitalization of $676.53M compared with $573.48M for Tactile Systems Technology (TCMD).

Which stock has performed better over the past year, BVS or TCMD?

BVS returned +36.46% over the past 12 months, compared with -0.39% for TCMD (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, BVS or TCMD?

BVS has the lower trailing P/E at 12.2, versus 24.9 for TCMD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Bioventus and Tactile Systems Technology in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons